Article Text

Download PDFPDF
Weakening the ethical distinction between euthanasia, palliative opioid use and palliative sedation
  1. Thomas David Riisfeldt
  1. Department of Philosophy, University of New South Wales, Sydney, New South Wales, Australia
  1. Correspondence to Dr Thomas David Riisfeldt, Department of Philosophy, University of New South Wales, Sydney NSW 2052, Australia; ThomasDavid.Riisfeldt{at}health.nsw.gov.au

Abstract

Opioid and sedative use are common ‘active’ practices in the provision of mainstream palliative care services, and are typically distinguished from euthanasia on the basis that they do not shorten survival time. Even supposing that they did, it is often argued that they are justified and distinguished from euthanasia via appeal to Aquinas’ Doctrine of Double Effect. In this essay, I will appraise the empirical evidence regarding opioid/sedative use and survival time, and argue for a position of agnosticism. I will then argue that the Doctrine of Double Effect is a useful ethical tool but is ultimately not a sound ethical principle, and even if it were, it is unclear whether palliative opioid/sedative use satisfy its four criteria. Although this essay does not establish any definitive proofs, it aims to provide reasons to doubt—and therefore weaken—the often-claimed ethical distinction between euthanasia and palliative opioid/sedative use.

  • euthanasia
  • palliative care
  • end-of-life-care
  • elderly and terminally ill

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors The author conceived, researched, wrote and edited this essay.

  • Funding The author has not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles